Centre for Liver and Gastrointestinal Research

Medicine & Life Sciences

1. Liver Diseases 100%
2. Liver Transplantation 98%
3. Liver 97%
4. Non-alcoholic Fatty Liver Disease 74%
5. Fatty Liver 68%
6. Glucagon-Like Peptide-1 Receptor 57%
7. Cell- and Tissue-Based Therapy 56%
8. Inflammatory Bowel Diseases 55%
9. semaglutide 51%
10. Fecal Microbiota Transplantation 42%
11. Mesenchymal Stem Cells 40%
12. Type 2 Diabetes Mellitus 40%
13. Acute Liver Failure 40%
14. Scavenger Receptors 38%
15. Risk Management 37%
16. Sarcopenia 36%
17. Human Embryonic Stem Cells 35%
18. Liver Cirrhosis 35%
19. Obesity 34%
20. Inflammation 33%
21. Fluorescent Dyes 31%
22. Liver Neoplasms 29%
23. Cardiology 29%
24. Fibrosis 29%
25. End Stage Liver Disease 29%
26. Anti-Inflammatory Agents 29%
27. Chronic Disease 25%
28. Therapeutics 25%
29. Microscopy 24%
30. Perfusion 22%
31. Communication 22%
32. Cardiovascular Diseases 21%
33. Population 21%
34. Placebos 20%
35. Chronic Renal Insufficiency 20%
36. Pediatrics 19%
37. Clinical Studies 18%
38. Dysbiosis 18%
39. T-Lymphocytes 18%
40. Transplants 17%
41. Comorbidity 17%
42. Research Ethics 16%
43. Regulatory T-Lymphocytes 15%
44. Gastrointestinal Microbiome 14%
45. Health 14%
46. Homeostasis 14%
47. Metabolic Syndrome 13%
48. Psychology Recognition 13%
49. Hepatocellular Carcinoma 11%
50. Extracellular Vesicles 11%
51. Informed Consent 11%
52. Names 11%
53. Loss of Function Mutation 11%
54. Gastric Inhibitory Polypeptide 10%
55. Organ Transplantation 10%
56. Wounds and Injuries 10%
57. Sodium-Glucose Transport Proteins 10%
58. Gastroenterology 10%
59. Complementary Therapies 10%
60. Mineralocorticoid Receptor Antagonists 9%
61. Disease Progression 9%
62. Infections 9%
63. Hepatitis 9%
64. Inborn Genetic Diseases 9%
65. HLA Antigens 9%
66. Hepatic Veins 8%
67. Drug Therapy 8%
68. Safety 8%
69. Hepatic Artery 8%
70. Healthy Diet 8%
71. Abdominal Obesity 8%
72. Macrophages 8%
73. Hepatocytes 8%
74. Hypertension 8%
75. Complement Receptors 7%
76. Pandemics 7%
77. Gastrointestinal Diseases 7%
78. Diabetes Mellitus 7%
79. Immune System 7%
80. Allografts 7%
81. Tobacco Use 7%
82. Portal Vein 7%
83. Pattern Recognition Receptors 7%
84. Disease Management 7%
85. Microbiota 7%
86. Cardiovascular System 7%
87. Berlin 7%
88. Dyslipidemias 7%
89. Morbidity 6%
90. Hospital Costs 6%
91. Social Identification 6%
92. Viruses 6%
93. Overweight 6%
94. Allogeneic Cells 6%
95. Transplant Recipients 6%
96. Weight Loss 6%
97. Insulin Resistance 6%
98. Life Style 6%
99. Ethics 6%
100. oxidized low density lipoprotein 5%